Indeed, ERK activation is causally linked to inflammation in many instances: oncogenic KRAS G12V drives inflammation in mice and human leukemic monocytes (66), and ERK inhibition blocks inflammation due to cerebral ischemia in mice (74). This evidence concerns the gene KRAS and Cerebral ischemia.